The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Abstract
OBJECTIVES: Patients with RA have an increased prevalence of cardiovascular disease (CVD). This is due to traditional risk factors and the effects of chronic inflammation. MTX is the first-choice DMARD in RA. We performed a systematic literature review to determine whether MTX affects the risk of CVD in patients with RA. METHODS: We searched Medline, Embase, Cochrane database, database of abstracts of reviews of effects, health technology assessment and Science Citation Index from 1980 to 2008. Conference proceedings (British Society of Rheumatology, ACR and EULAR) were searched from 2005 to 2008. Papers were included if they assessed the relationship between MTX use and CVD in patients with RA. Two reviewers independently assessed each title and abstract for relevance and quality. RESULTS: A total of 2420 abstracts were identified, of which 18 fulfilled the inclusion criteria. Two studies assessed the relationship between MTX use and CVD mortality, one demonstrated a significant reduction in CVD mortality and the second a trend towards reduction. Five studies considered all-cause CVD morbidity. Four demonstrated a significant reduction in CVD morbidity and the fifth a trend towards reduction. MTX use in the year prior to the development of RA decreased the risk of CVD for 3-4 years. Four studies considered myocardial infarction, one demonstrated a decreased risk and three a trend towards decreased risk with MTX use. CONCLUSION: The current evidence suggests that MTX use is associated with a reduced risk of CVD events in patients with RA. This suggests that reducing the inflammation in RA using MTX not only improves disease-specific outcomes but may also reduce collateral damage such as atherosclerosis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Non-randomized observational studies report reductions in rates of vascular events and cardiovascular death among both rheumatoid arthritis and psoriasis patients being treated with weekly methotrexate in doses ranging from 10 to 20 mg.
“Non-randomized observational studies report reductions in rates of vascular events and cardiovascular death among both rheumatoid arthritis and psoriasis patients being treated with weekly methotrexate in doses ranging from 10 to 20 mg.187,188”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674 · see citing works
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641 · see citing works
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531 · see citing works
Being big or growing fast: systematic review of size and growth in infancy and later obesity
Baird, J., Fisher, D., Lucas, P., Kleijnen, J., Roberts, H., & Law, C. (2005) · BMJ · doi:10.1136/bmj.38586.411273.e0 · Cited by 1,185 · see citing works
Self-citationMethotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. Á., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127 · see citing works
Cardiovascular Risk and Inhibition of Cyclooxygenase
McGettigan, P., & Henry, D. A. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,096 · see citing works
Cardiovascular death in rheumatoid arthritis: A population‐based study
Kremers, H. M., Nicola, P., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 934 · see citing works
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N. A., McCarey, D. W., Capell, H. A., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 932 · see citing works
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E., Coblyn, J. S., Fox, D. A., Fraser, P. A., Holdsworth, D. E., Glass, D. N., & Trentham, D. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121303 · Cited by 872 · see citing works
Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645 · see citing works
Dixon, W. G., Watson, K. D., Lunt, M., Hyrich, K. L., Silman, A. J., & Symmons, D. P. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22809 · Cited by 557 · see citing works
The risk of congestive heart failure in rheumatoid arthritis: A population‐based study over 46 years
Nicola, P., Kremers, H. M., Roger, V. L., Jacobsen, S. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20855 · Cited by 484 · see citing works
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
Naranjo, A., Sokka, T., Descalzo, M. Á., Alén, J. C., Hørslev‐Petersen, K., Luukkainen, R., Combe, B. G., Burmester, G. R., Devlin, J., Ferraccioli, G., et al. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2383 · Cited by 464 · see citing works
Self-citationWilliams, H. J., Willkens, R. F., Samuelson, C. O., Alarcón, G. S., Guttadauria, M., Yarboro, C. H., Polisson, R. P., Weiner, S. R., Luggen, M. E., Billingsley, L. M., et al. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280702 · Cited by 462 · see citing works
Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist
Kwon, H., Cot, T. R., Cuffe, M. S., Kramer, J. M., & Braun, M. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-10-200305200-00008 · Cited by 455 · see citing works
van Dongen, H., van Aken, J., Lard, L. R., Visser, K., Ronday, H. K., Hulsmans, H. M. J., Speyer, I., Westedt, M. L., Peeters, A. J., Allaart, C. F., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22525 · Cited by 413 · see citing works
Mortality in rheumatoid arthritis
Myllykangas-Luosuj→vi, R. A., Aho, K., & Isomäki, H. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80031-x · Cited by 385 · see citing works
PRODANOWICH, S., MA, F., TAYLOR, J., PEZON, C., FASIHI, T., & KIRSNER, R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.06.017 · Cited by 384 · see citing works
Young, A., Koduri, G., Batley, M., Kulinskaya, E., Gough, A., Norton, S., Dixey, J., & on behalf of the Early Rheumatoid Arthritis Study (ERAS) group (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel253 · Cited by 353 · see citing works
Weekly Pulse Methotrexate in Rheumatoid Arthritis
ANDERSEN, P. A., West, S. G., O’Dell, J. R., Via, C. S., Claypool, R., & Kotzin, B. L. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-489 · Cited by 331 · see citing works
Symmons, D. P. M., Jones, M., Scott, D. L., & Prior, P. (1998) · PubMed · Cited by 319 · see citing works
Kumeda, Y., Inaba, M., Goto, H., Nagata, M., Henmi, Y., Furumitsu, Y., Ishimura, E., Inui, K., Yutani, Y., Miki, T., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10269 · Cited by 307 · see citing works
Hypertension in rheumatoid arthritis
Panoulas, V. F., Metsios, G. S., Pace, A. V., John, H., Treharne, G. J., Banks, M., & Kitas, G. D. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken159 · Cited by 304 · see citing works
Goodson, N. J., Symmons, D. P. M., Scott, D. G. I., Bunn, D. K., Lunt, M., & Silman, A. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21204 · Cited by 287 · see citing works
de Bree, A., Verschuren, W. M. M., Kromhout, D., Kluijtmans, L. A. J., & Blom, H. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.599 · Cited by 283 · see citing works
van Halm, V. P., Nurmohamed, M. T., Twisk, J. W. R., Dijkmans, B. A. C., & Voskuyl, A. E. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2045 · Cited by 267 · see citing works
CAUSE OF DEATH IN RHEUMATOID ARTHRITIS
Prior, P., Symmons, D. P. M., Scott, D. L., BROWN, R., & Hawkins, C. F. (1984) · Lara D. Veeken · doi:10.1093/rheumatology/23.2.92 · Cited by 248 · see citing works
Georgiadis, A. N., Papavasiliou, E. C., Lourida, E. S., Alamanos, Y., Kostara, C. E., Tselepis, A. D., & Drosos, A. A. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1952 · Cited by 247 · see citing works
Badger, A. M., Griswold, D. E., Kapadia, R. D., Blake, S. M., Swift, B. A., Hoffman, S. J., Stroup, G. B., Webb, E. F., Rieman, D. J., Gowen, M., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1 · Cited by 213 · see citing works
Antirheumatic drug use and the risk of acute myocardial infarction
Suissa, S., Bernatsky, S., & Hudson, M. (2006) · Arthritis Care & Research · doi:10.1002/art.22094 · Cited by 184 · see citing works
Homocysteine and folate status in methotrexate‐treated patients with rheumatoid arthritis
van Ede, A. E., Laan, R., Blom, H. J., Boers, G. H. J., HAAGSMA, C. J., Thomas, C. M. G., de Boo, T. M., & van de Putte, L. B. A. (2002) · Lara D. Veeken · doi:10.1093/rheumatology/41.6.658 · Cited by 183 · see citing works
Systemic inflammation as a risk factor for atherothrombosis
van Leuven, S. I., Franssen, R., Kastelein, J. J. P., Levi, M. M., Stroes, E. S. G., & Tak, P. P. (2007) · Lara D. Veeken · doi:10.1093/rheumatology/kem202 · Cited by 179 · see citing works
Thompson, R. N., Watts, C., Edelman, J., Esdaile, J. M., & Russell, A. S. (1984) · PubMed · Cited by 178 · see citing works
Park, Y., Choi, H. K., Kim, M.-Y., Lee, W. K., Song, J., Kim, D.-K., & Lee, S.-K. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01186-5 · Cited by 176 · see citing works
Mortality in established rheumatoid arthritis
Naz, S. M., & Symmons, D. P. M. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.05.003 · Cited by 174 · see citing works
THE COST OF RHEUMATOID ARTHRITIS
McIntosh, E. (1996) · Lara D. Veeken · doi:10.1093/rheumatology/35.8.781 · Cited by 171 · see citing works
Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
Landewé, R., van den Borne, B. E., Breedveld, F. C., & Dijkmans, B. A. C. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02222-4 · Cited by 158 · see citing works
Morgan, S. L., Baggott, J. E., Lee, J. Y., & Alarcón, G. S. (1998) · PubMed · Cited by 155 · see citing works
Scott, D. L., Shipley, M. E., Dawson, A., Edwards, S. M., Symmons, D. P. M., & Woolf, A. D. (1998) · Lara D. Veeken · doi:10.1093/rheumatology/37.5.546 · Cited by 155 · see citing works
Corticosteroids: do they damage the cardiovascular system?
Maxwell, S. R. J., Moots, R. J., & Kendall, M. J. (1994) · Postgraduate Medical Journal · doi:10.1136/pgmj.70.830.863 · Cited by 154 · see citing works
Bernatsky, S., Hudson, M., & Suissa, S. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/keh610 · Cited by 154 · see citing works
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis
Munro, R., Morrison, E., McDonald, A. G., Hunter, J. A., Madhok, R., & Capell, H. A. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.6.374 · Cited by 134 · see citing works
Krishnan, E., Lingala, V. B., & Singh, G. (2004) · Circulation · doi:10.1161/01.cir.0000142864.83780.81 · Cited by 120 · see citing works
Hochberg, M. C., Johnston, S. S., & John, A. K. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x261177 · Cited by 114 · see citing works
Rozman, B., Praprotnik, S., Logar, D., Tomšič, M., Hojnik, M., Kos-Golja, M., Accetto, R., & Dolenc, P. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.567 · Cited by 104 · see citing works
Rheumatoid arthritis and cardiovascular disease
Dhawan, S. S., & Quyyumi, A. A. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0019-x · Cited by 98 · see citing works
Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?
Wållberg‐Jonsson, S., Öhman, M.-L., & Rantapää‐Dahlqvist, S. (2004) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740410010308 · Cited by 87 · see citing works
Dessein, P. H., Joffe, B. I., & Stanwix, A. E. (2002) · Arthritis Research & Therapy · doi:10.1186/ar597 · Cited by 85 · see citing works
Chollet-Janin, A., Finckh, A., Dudler, J., & Guerne, P. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22389 · Cited by 80 · see citing works
Edwards, C. J., Arden, N., Fisher, D., Saperia, J., Reading, I., van Staa, T. P., & Cooper, C. C. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/kei024 · Cited by 70 · see citing works
Self-citationEdwards, C. J., Syddall, H. E., Goswami, R., Goswami, P., Dennison, E. M., Arden, N., Cooper, C. C., & on behalf of the Hertfordshire Cohort Study Group (2007) · Heart · doi:10.1136/hrt.2006.097816 · Cited by 62 · see citing works
Self-citationDisease activity as a risk factor for myocardial infarction in rheumatoid arthritis
Radovits, B. J., Popa-Diaconu, D. A., Popa, C. D., Eijsbouts, A. M. M., Laan, R., van Riel, P. L. C. M., & Fransen, J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089862 · Cited by 54 · see citing works
Kvien, T. K., Zeidler, H., Hannonen, P., Wollheim, F. A., Førre, Ø. T., Hafström, I., Kaltwasser, J. P., Leirisalo‐Repo, M., Manger, B., Laasonen, L., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.511 · Cited by 32 · see citing works
Goodson, N. J., Farragher, T. M., & Symmons, D. P. M. (2008) · PubMed · Cited by 25 · see citing works
Seriolo, B., Paolino, S., Ferrone, C., & Cutolo, M. (2008) · PubMed · Cited by 22 · see citing works
Flagged first, then by citations
2 of the 57 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490 · see citing works
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,840 · see citing works
Smolen, J. S., Landewé, R., Breedveld, F. C., Buch, M. H., Burmester, G. R., Dougados, M., Emery, P., Gaujoux-Viala, C., Gossec, L., Nam, J. L., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204573 · Cited by 1,764 · see citing works
Smolen, J. S., Breedveld, F. C., Burmester, G. R., Bykerk, V. P., Dougados, M., Emery, P., Kvien, T. K., Navarro-Compán, M. V., Oliver, S. M., Schoels, M., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207524 · Cited by 1,481 · see citing works
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M. T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,409 · see citing works
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Ridker, P. M., Everett, B. M., Pradhan, A., MacFadyen, J. G., Solomon, D. H., Zaharris, E., Mam, V., Hasan, A., Rosenberg, Y., Iturriaga, E., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809798 · Cited by 1,317 · see citing works
Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J., Lynde, C., Pope, J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206624 · Cited by 907 · see citing works
Authors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863 · see citing works
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 693 · see citing works
Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
Micha, R., Imamura, F., von Ballmoos, M. C. W., Solomon, D. H., Hernán, M. Á., Ridker, P. M., & Mozaffarian, D. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.054 · Cited by 535 · see citing works
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 456 · see citing works
Mason, J. C., & Libby, P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu403 · Cited by 420 · see citing works
Papp, K. A., Griffiths, C. E. M., Gordon, K. B., Lebwohl, M., Szapary, P. O., Wasfi, Y. S., Chan, D., Hsu, M.-C., Ho, V., Ghislain, P., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12214 · Cited by 411 · see citing works
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
Symmons, D. P. M., & Gabriel, S. E. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.75 · Cited by 406 · see citing works
Anti-inflammatory therapies for atherosclerosis
Bäck, M., & Hansson, G. K. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.5 · Cited by 380 · see citing works
Barnabe, C. C. M., Martin, B., & Ghali, W. A. (2010) · Arthritis Care & Research · doi:10.1002/acr.20371 · Cited by 372 · see citing works
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
Kitas, G. D., & Gabriel, S. E. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.142133 · Cited by 320 · see citing works
European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)
Perk, J., Backer, G. D., Gohlke, H., Graham, I. M., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cífková, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 313 · see citing works
Choy, E., Ganeshalingam, K., Semb, A., Szekanecz, Z., & Nurmohamed, M. (2014) · Rheumatology · doi:10.1093/rheumatology/keu224 · Cited by 320 · see citing works
Self-citationAtherosclerosis in rheumatoid arthritis: is it all about inflammation?
Skeoch, S., & Bruce, I. N. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.40 · Cited by 281 · see citing works
Crowson, C. S., Matteson, E. L., Roger, V. L., Therneau, T. M., & Gabriel, S. E. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.03.044 · Cited by 268 · see citing works
Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Ridker, P. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313129 · Cited by 260 · see citing works
Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study
van den Hoek, J., Boshuizen, H. C., Roorda, L. D., Tijhuis, G. J., Nurmohamed, M. T., van den Bos, G. A. M., & Dekker, J. (2016) · Rheumatology International · doi:10.1007/s00296-016-3638-5 · Cited by 238 · see citing works
Nast, A., Smith, C. H., Spuls, P. I., VALLE, G. L. A., Bata‐Csörgõ, Z., Boonen, H., de Jong, E. M. G. J., García-Doval, I., Gisondi, P., Kaur‐Knudsen, D., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16926 · Cited by 232 · see citing works
Cardiorheumatology: cardiac involvement in systemic rheumatic disease
Prasad, M., Hermann, J., Gabriel, S. E., Weyand, C. M., Mulvagh, S. L., Mankad, R., Oh, J. K., Matteson, E. L., & Lerman, A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.206 · Cited by 213 · see citing works
Westlake, S., Colebatch, A. N., Baird, J., Curzen, N. P., Kiely, P. D. W., Quinn, M. A., Choy, E., Östör, A. J. K., & Edwards, C. J. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq316 · Cited by 213 · see citing works
Self-citationArida, A., Protogerou, A. D., Kitas, G. D., & Sfikakis, P. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071890 · Cited by 196 · see citing works
Parisi, R., Rutter, M. K., Lunt, M., Young, H. S., Symmons, D. P. M., Griffiths, C. E. M., & Ashcroft, D. M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.87 · Cited by 182 · see citing works
Ahlehoff, O., Skov, L., Gislason, G., Lindhardsen, J., Kristensen, S. L., Iversen, L., Lasthein, S., Gniadecki, R., Dam, T. N., Torp-Pedersen, C. T., et al. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02593.x · Cited by 177 · see citing works
Liao, K. P., & Solomon, D. H. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes243 · Cited by 176 · see citing works
Zöller, B., Li, X., Sundquist, J., & Sundquist, K. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-41 · Cited by 173 · see citing works
Hugh, J. M., Voorhees, A. S. V., Nijhawan, R. I., Bagel, J., Lebwohl, M., Blauvelt, A., Hsu, S., & Weinberg, J. M. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.020 · Cited by 157 · see citing works
Zöller, B., Li, X., Sundquist, J., & Sundquist, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033442 · Cited by 154 · see citing works
The epidemiology of established rheumatoid arthritis
Otón, T., & Carmona, L. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.101477 · Cited by 151 · see citing works
Charles‐Schoeman, C., Wicker, P. A., González-Gay, M. Á., Boy, M. G., Zuckerman, A. L., Soma, K., Geier, J. L., Kwok, K. K., & Riese, R. J. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.05.014 · Cited by 139 · see citing works
Co-morbidities in established rheumatoid arthritis
Gullick, N., & Scott, D. L. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.009 · Cited by 136 · see citing works
Novel anti-inflammatory therapies for the treatment of atherosclerosis
Khan, R., Spagnoli, V., Tardif, J., & L’Allier, P. L. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.783 · Cited by 128 · see citing works
Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Fleming, P., Siu, S., Kraft, J. N., Lynde, C. W., Pope, J. E., et al. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.141112 · Cited by 127 · see citing works
Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
Lee, J. L., Sinnathurai, P., Buchbinder, R., Hill, C. L., Lassere, M. N., & MARCH, L. M. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1669-x · Cited by 123 · see citing works
Moreira, D. M., da Silva, R. L., Vieira, J. L., Fattah, T., Lueneberg, M. E., & Gottschall, C. A. M. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0094-z · Cited by 117 · see citing works
The Influence of Rheumatoid Arthritis Disease Characteristics on Heart Failure
Myasoedova, E., Crowson, C. S., Nicola, P., Kremers, H. M., Davis, J. M., Roger, V. L., Therneau, T. M., & Gabriel, S. E. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100979 · Cited by 116 · see citing works
Propensity‐adjusted association of methotrexate with overall survival in rheumatoid arthritis
Wasko, M. C., Dasgupta, A., Hubert, H. B., Fries, J. F., & Ward, M. M. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37723 · Cited by 114 · see citing works
Cardiovascular effects of approved drugs for rheumatoid arthritis
Atzeni, F., Rodríguez‐Carrio, J., Popa, C. D., Nurmohamed, M. T., Szűcs, G., & Szekanecz, Z. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00593-3 · Cited by 109 · see citing works
Statins and inflammation: an update
Quist‐Paulsen, P. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283398e53 · Cited by 109 · see citing works
Risk factors for cardiovascular disease in rheumatoid arthritis
Gabriel, S. E., & Crowson, C. S. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834ff2fd · Cited by 102 · see citing works
Comorbidity in inflammatory bowel disease
López–Sanromán, A. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i22.2723 · Cited by 102 · see citing works
Yamamoto, K., Goto, H., Hirao, K., Nakajima, A., Origasa, H., Tanaka, K., Tomobe, M., & Totsuka, K. (2015) · Journal of Rheumatology · doi:10.3899/jrheum.141210 · Cited by 100 · see citing works
Özen, G., Pedro, S., & Michaud, K. D. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.200265 · Cited by 96 · see citing works
Treatment With Methotrexate Inhibits Atherogenesis in Cholesterol-Fed Rabbits
Bulgarelli, A., Dias, A. A. M., Caramelli, B., & Maranhão, R. C. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318241c385 · Cited by 95 · see citing works
Mikuls, T. R., Fay, B. T., Michaud, K. D., Sayles, H. R., Thiele, G. M., Caplan, L., Johnson, D. S., Richards, J. S., Kerr, G. S., Cannon, G. W., et al. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq232 · Cited by 95 · see citing works
Inflammation, Immune Activation, and CVD Risk in Individuals With HIV Infection
Stein, J. H., & Hsue, P. Y. (2012) · JAMA · doi:10.1001/jama.2012.8488 · Cited by 94 · see citing works
How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?
Kerola, A. M., Kauppi, M. J., Kerola, T. V., & Nieminen, T. V. M. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201334 · Cited by 88 · see citing works
Update on the NCEP ATP-III emerging cardiometabolic risk factors
Eckel, R. H., & Cornier, M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-115 · Cited by 90 · see citing works
Atzeni, F., Turiel, M., Caporali, R. F., Cavagna, L., TOMASONI, L., Sitia, S., & Sarzi‐Puttini, P. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.07.018 · Cited by 84 · see citing works
Marks, J. L., & Edwards, C. J. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x11436239 · Cited by 83 · see citing works
Self-citationAtherosclerosis and Rheumatoid Arthritis: More Than a Simple Association
Cavagna, L., Boffini, N., Cagnotto, G., Inverardi, F., Grosso, V., & Caporali, R. F. (2012) · Mediators of Inflammation · doi:10.1155/2012/147354 · Cited by 79 · see citing works
Atherosclerosis and Coronary Artery Disease
Zaromitidou, M., Siasos, G., Παπαγεωργίου, Ν., Oikonomou, E. K., & Tousoulis, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803312-8.00002-1 · Cited by 80 · see citing works
Tandon, R., Chew, G. M., Byron, M. M., Borrow, P., Niki, T., Hirashima, M., Barbour, J. D., Norris, P. J., Lanteri, M. C., Martin, J. N., et al. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0004 · Cited by 77 · see citing works
Managing the drug treatment of rheumatoid arthritis
Wilsdon, T. D., & Hill, C. L. (2017) · Australian Prescriber · doi:10.18773/austprescr.2017.012 · Cited by 77 · see citing works
Martínez, M. A. M., González‐Juanatey, C., Castañeda, S., Llorca, J., Ferraz‐Amaro, I., Fernández‐Gutiérrez, B., Díaz‐González, F., & González-Gay, M. Á. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.01.002 · Cited by 76 · see citing works
Bili, A., Tang, X., Pranesh, S., Bozaite, R., Morris, S. J., Antohe, J. L., Kirchner, H. L., & Wasko, M. C. M. (2014) · Arthritis Care & Research · doi:10.1002/acr.22166 · Cited by 75 · see citing works
Charles‐Schoeman, C., DeMasi, R., Valdez, H., Soma, K., Hwang, L., Boy, M. G., Biswas, P., & McInnes, I. B. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40911 · Cited by 75 · see citing works
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
Judge, A., Garriga, C., Arden, N., Lovestone, S., Prieto‐Alhambra, D., Cooper, C. C., & Edwards, C. J. (2017) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.10.002 · Cited by 76 · see citing works
Self-citationLauper, K., Courvoisier, D. S., Chevallier-Ruggeri, P., Finckh, A., & Gabay, C. (2018) · Arthritis Care & Research · doi:10.1002/acr.23567 · Cited by 75 · see citing works
Cardiovascular Comorbidity in Rheumatic Diseases
Wright, K., Crowson, C. S., & Gabriel, S. E. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.10.003 · Cited by 73 · see citing works
Misra, D. P., & Shenoy, S. (2016) · Rheumatology International · doi:10.1007/s00296-016-3435-1 · Cited by 69 · see citing works
Ajeganova, S., Fairé, U. D., Jogestrand, T., Frostegård, J., & Hafström, I. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111334 · Cited by 67 · see citing works
Deyab, G., Hokstad, I., Whist, J. E., Småstuen, M. C., Agewall, S., Lyberg, T., Ronda, N., Mikkelsen, K., Hjeltnes, G., & Hollan, I. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1439-1 · Cited by 67 · see citing works
New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis
Mahmoudi, M., Aslani, S., Fadaei, R., & Jamshidi, A. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12999 · Cited by 62 · see citing works
Closing the loop on inflammation and atherothrombosis: why perform the CIRT and CANTOS trials?
Ridker, P. M. (2013) · Europe PMC (PubMed Central) · Cited by 64 · see citing works
Rollefstad, S., Ikdahl, E., Hisdal, J., Olsen, I. C., Holme, I., Hammer, H. B., Smerud, K. T., Kitas, G. D., Pedersen, T. R., Kvien, T. K., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39114 · Cited by 65 · see citing works
Inflammation modulation and cardiovascular disease prevention
Awan, Z. A., & Genest, J. J. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314529350 · Cited by 65 · see citing works
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.010 · Cited by 65 · see citing works
Armstrong, A. W., Paul, C. F., Puig, L., Boehncke, W., Freeman, M., Torii, H., Papp, K. A., Griffiths, C. E. M., Blauvelt, A., Reich, K., et al. (2019) · Dermatology and Therapy · doi:10.1007/s13555-019-00340-3 · Cited by 65 · see citing works
Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy?
Ziegler, M., Wallert, M., Lorkowski, S., & Peter, K. (2020) · Antioxidants · doi:10.3390/antiox9100935 · Cited by 64 · see citing works
Cardiovascular Risk in Rheumatoid Arthritis
Gkaliagkousi, Ε., Gavriilaki, E., Doumas, M. N., Petidis, K., Aslanidis, S., & Δούμα, Σ. (2012) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31827846b1 · Cited by 63 · see citing works
Inflammatory Diseases and Vitamin E—What Do We Know and Where Do We Go?
Wallert, M., Börmel, L., & Lorkowski, S. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000097 · Cited by 66 · see citing works
Combating Inflammation in Cardiovascular Disease
Sethwala, A., Goh, I. Y., & Amerena, J. V. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.09.003 · Cited by 62 · see citing works
Methotrexate in Atherogenesis and Cholesterol Metabolism
Coomes, E., Chan, E. S. L., & Reiss, A. B. (2011) · Cholesterol · doi:10.1155/2011/503028 · Cited by 61 · see citing works
Systemic methotrexate for the treatment of psoriasis
Yélamos, O., & Puig, L. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1026894 · Cited by 61 · see citing works
Cardiovascular risk in rheumatoid arthritis: How to lower the risk?
der Stoep, D. F. V. B.-V., Klop, B., van Zeben, D., Hazes, J. M. W., & Cabezas, M. C. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.09.006 · Cited by 60 · see citing works
Inflammation in atherosclerotic cardiovascular disease
Shah, P. K., & Lecis, D. (2019) · F1000Research · doi:10.12688/f1000research.18901.1 · Cited by 58 · see citing works
Inflammation and dementia: Using rheumatoid arthritis as a model to develop treatments?
Mason, A., Holmes, C., & Edwards, C. J. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.04.001 · Cited by 59 · see citing works
Self-citationSemb, A. G., Rollefstad, S., van Riel, P. L. C. M., Kitas, G. D., Matteson, E. L., & Gabriel, S. E. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204792 · Cited by 57 · see citing works
Mantel, Ä., Holmqvist, M. E., Nyberg, F., Tornling, G., Frisell, T., Alfredsson, L. S., & Askling, J. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39267 · Cited by 57 · see citing works
Rheumatoid arthritis and cardiovascular disease
Barbhaiya, M., & Solomon, D. H. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835fd7f8 · Cited by 57 · see citing works
Tam, L., Li, E. K., Shang, Q., Tomlinson, B., Li, M., Leung, Y.-Y., Kuan, W.-P., Kwok, L., Li, T. K., Zhu, Y., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131359 · Cited by 56 · see citing works
Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis
O'Neill, F., Charakida, M., Topham, E., McLoughlin, E., Patel, N. P., Sutill, E., Kay, C. W. M., D’Aiuto, F., Landmesser, U., Taylor, P. C., et al. (2016) · Heart · doi:10.1136/heartjnl-2015-308953 · Cited by 55 · see citing works
Atherosclerosis in psoriatic disease: latest evidence and clinical implications
Eder, L., & Gladman, D. D. (2015) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x15591801 · Cited by 54 · see citing works
Cardiovascular safety of biologic therapies for the treatment of RA
Greenberg, J., Furer, V., & Farkouh, M. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.168 · Cited by 53 · see citing works
King, A., Schmaier, A., Harth, K. C., Kumins, N., Wong, V. L., Zidar, D. A., Kashyap, V., & Cho, J.-S. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.10.058 · Cited by 43 · see citing works
Immune-mediated mechanisms of atherosclerosis and implications for the clinic
Nus, M., & Mallat, Z. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1195686 · Cited by 44 · see citing works
Cardiovascular disease risk in rheumatoid arthritis: Progress, debate, and opportunity
Kramer, H. R., & Giles, J. T. (2010) · Arthritis Care & Research · doi:10.1002/acr.20386 · Cited by 52 · see citing works
A critical view on cardiovascular risk in systemic sclerosis
Psarras, A., Σουλαϊδόπουλος, Σ., Garyfallos, A., Kitas, G. D., & Dimitroulas, T. (2016) · Rheumatology International · doi:10.1007/s00296-016-3530-3 · Cited by 52 · see citing works
An, J., Nyarko, E., & Hamad, M. A. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04613-2 · Cited by 52 · see citing works
Effect of Anti-Rheumatic Drugs on Cardiovascular Disease Events in Rheumatoid Arthritis
Yang, B., Ma, D., Xingxing, Z., Zhu, X., Yajing, W., Xu, K., & Liyun, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.812631 · Cited by 51 · see citing works
Nurmohamed, M. T., Bao, Y., Signorovitch, J., Trahey, A., Mulani, P. M., & Furst, D. E. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000080 · Cited by 51 · see citing works
López-Pedrera, C., Aguirre, M. A., Barbarroja, N., & Cuadrado, M. J. (2010) · BioMed Research International · doi:10.1155/2010/607084 · Cited by 50 · see citing works
Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis
Bertrand, M.-J., & Tardif, J. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2017.1269743 · Cited by 51 · see citing works
Houge, I. S., Hoff, M., Thomas, R., & Videm, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-60621-2 · Cited by 52 · see citing works
- Authors
- Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J.
- Affiliations
- King's College London (GB)
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-27
- Volume
- 49
- Issue
- 2
- Pages
- 295-307
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2100260684
- Cited by
- 357
- References
- 57
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 15 · 2021: 18 · 2020: 15 · 2019: 26 · 2018: 20 · 2017: 25 · 2016: 32 · 2015: 38 · 2014: 25 · 2013: 33 · 2012: 42
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lara D. Veeken (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Pharmacology › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- methotrexate, rheumatoid arthritis, cardiovascular disease, cardiovascular mortality, cardiovascular morbidity, myocardial infarction, atherosclerosis, disease-modifying antirheumatic drugs, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Cardiovascular Diseases, Humans, Immunosuppressive Agents, Insulin Resistance, Lipids, Methotrexate, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
